MAD-ID The Antimicrobial Stewardship Meeting
LightNews LightNews
banner
mad-id.bsky.social
MAD-ID The Antimicrobial Stewardship Meeting
@mad-id.bsky.social
720 followers 54 following 68 posts
We lead in Infectious Diseases through bold exchange of knowledge, amplifying scientific discovery, and empowering infectious diseases pharmacists, trainees, and clinicians. #MADID2025

https://www.mad-id.org/
Posts Replies Media Videos
Pinned
mad-id.bsky.social
MAD-ID The Antimicrobial Stewardship Meeting @mad-id.bsky.social · Oct 14
📣 Save the Date! 📣
Our 1️⃣st ever MAD-ID 🤝 SIDP 2026 Annual Meeting! 🔥
📆 May 14-17, 2026 in Orlando, FL 🌴
More details to come! 👀
@sidpharm.bsky.social
mad-id.bsky.social
This week we are thankful for Liz Chandler from our MAD-ID Communications Team! #MeetMADID
November 25, 2025 at 3:03 PM
mad-id.bsky.social
Fighting AR takes all of us and everyone can play a role. bit.ly/4lVnLGF #USAAW25
November 19, 2025 at 4:03 PM
mad-id.bsky.social
MAD-ID goes (well, stays) 💜 PURPLE 💜 for US Antibiotic 💊 Awareness Week!
bit.ly/4lVnLGF #USAAW25
November 18, 2025 at 1:02 PM
mad-id.bsky.social
Meet Stormmy Boettcher from our MAD-ID Communications Team!
#MeetMADID
November 17, 2025 at 5:02 PM
mad-id.bsky.social
📣 Save the Date! 📣
Our 1️⃣st ever MAD-ID 🤝 SIDP 2026 Annual Meeting! 🔥
📆 May 14-17, 2026 in Orlando, FL 🌴
More details to come! 👀
@sidpharm.bsky.social
October 14, 2025 at 2:02 PM
Reposted by MAD-ID The Antimicrobial Stewardship Meeting
sidpharm.bsky.social
📣 ICYMI We have big news! @mad-id.bsky.social and SIDP are teaming up for an annual meeting! This meeting will bring innovation and science (and BCIDP credit!) in ID pharmacotherapy, be accessible for all, and create a welcoming space to form life-long connections. Save the date: May 14-17, 2026.
July 10, 2025 at 12:02 PM
mad-id.bsky.social
LAST CHANCE BEFORE JULY 1st DEADLINE!

📣 Registration is now open for the 5️⃣th Annual Alabama Infectious Diseases Society (@ALInfectDis) Antimicrobial Stewardship 💊 Conference! ✨

🔗 Register here: aub.ethosce.com/content/alab...
June 26, 2025 at 1:05 PM
mad-id.bsky.social
📣 Registration is now open for the 5️⃣th Annual Alabama Infectious Diseases Society (ALIDS) Antimicrobial Stewardship 💊 Conference! ✨

🔗 Register here: aub.ethosce.com/content/alab...
June 16, 2025 at 1:03 PM
mad-id.bsky.social
📣 Attention Program Directors! Sign up is OPEN!

🌟 MAD-ID is excited to spotlight your PGY2 ID pharmacy residency or ID pharmacy fellowship program in the upcoming academic year!

🎓 See eligibility criteria!

Sign up: forms.office.com/r/86HfX98XqT

@SIDPharm.bsky.social
@accpinfdprn.bsky.social
June 9, 2025 at 12:02 PM
Reposted by MAD-ID The Antimicrobial Stewardship Meeting
contagionlive.bsky.social
🎥 At #MADID2025, Dr. Jose Alexander from @adventhealth.bsky.social in Orlando, discussed data that ceftolozane/tazobactam showed 98% susceptibility against ESBL E. coli but only 76% for K. pneumoniae. @mad-id.bsky.social #IDsky #MEDsky

Full interview: www.contagionlive.com/view/ceftolo...
Ceftolozane/Tazobactam Shows Strong Activity Against ESBL E coli, But Gaps Remain for K pneumoniae
At MAD-ID, Jose Alexander, MD, reports 98% susceptibility in ESBL E coli and 76% in K pneumoniae, underscoring the need for species-specific testing.
www.contagionlive.com
June 5, 2025 at 3:49 PM
Reposted by MAD-ID The Antimicrobial Stewardship Meeting
contagionlive.bsky.social
At #MADID2025, Dr. Alyssa Cox, PharmD, presented data showing fidaxomicin reduced 90-day C difficile recurrence rates to 7.9% vs. 19% with vancomycin, a 68.3% lower risk in high-risk hospitalized patients. @mad-id.bsky.social #IDsky #MEDsky

Listen here: www.contagionlive.com/view/fidaxom...
Fidaxomicin Reduces Recurrence Risk in High-Risk C difficile Infections
At MAD-ID, Alyssa Cox, PharmD, showed fidaxomicin reduces 90-day recurrence by 68.3% versus vancomycin, with rates of 7.9% vs. 19% in 176 hospitalized patients.
www.contagionlive.com
June 6, 2025 at 1:16 PM
Reposted by MAD-ID The Antimicrobial Stewardship Meeting
contagionlive.bsky.social
At #MADID2025, Dr's. Julia F. & Christina Lee from UNC Medical Center presented that immunocompromised patients on OPAT had a 27.1% 30-day readmission rate compared to 14.1% in non-immunocompromised patients. @mad-id.bsky.social #IDsky #MEDsky

Listen here: www.contagionlive.com/view/immunoc...
Immunocompromised Patients on OPAT Face Nearly Double the Risk of 30-Day Readmission
Christina Lee, PharmD, and Julia Donahue, PharmD, analyzed 533 encounters revealing a 27.1% readmission rate in immunocompromised patients versus 14.1% in non-immunocompromised patients.
www.contagionlive.com
June 4, 2025 at 3:21 PM
Reposted by MAD-ID The Antimicrobial Stewardship Meeting
contagionlive.bsky.social
🎥 At #MADID2025, Dr. William Mikesell from IU Health shared findings showing no significant difference in treatment failure between doxycycline (20%) and minocycline (16%) for bone & joint infections. @mad-id.bsky.social #IDsky #MEDsky

Listen here: www.contagionlive.com/view/no-sign...
No Significant Difference Between Doxycycline and Minocycline for Bone and Joint Infections
At MADID 2025, William R Mikesell, PharmD, presented data showing 20% vs 16% treatment failure rates in doxycycline and minocycline groups.
www.contagionlive.com
June 4, 2025 at 6:46 PM
Reposted by MAD-ID The Antimicrobial Stewardship Meeting
contagionlive.bsky.social
🎥 At #MADID2025, Dr. Marc Scheetz, from Midwestern University, shares how PK/PD modeling and AUC-based dosing are helping clinicians make safer, more personalized antibiotic decisions—right at the bedside. @mad-id.bsky.social #IDsky #MEDsky #AMRsky

Listen here: www.contagionlive.com/view/precisi...
Precision in Practice: PK/PD Modeling Advances Infectious Disease Care
At MAD-ID, Mark Sheets, PharmD, discusses how PK/PD modeling and AUC-based strategies offer safer, more precise antibiotic therapy.
www.contagionlive.com
June 3, 2025 at 1:00 PM
Reposted by MAD-ID The Antimicrobial Stewardship Meeting
letstalkmicro.bsky.social
Another great talk from #MADID2025 : Advances in Diagnostic and Laboratory
Science with @romneyintn.bsky.social

#microbiology @mad-id.bsky.social
June 2, 2025 at 4:21 PM
Reposted by MAD-ID The Antimicrobial Stewardship Meeting
contagionlive.bsky.social
#MADID2025 has wrapped up in Orlando, but we’re continuing our coverage. Look out for new interviews, research highlights, & expert insights all week! @mad-id.bsky.social #IDsky #MEDsky

🎥 Stay tuned for Dr. Tiffany Lee's interview this week!

Coverage: www.contagionlive.com/conference/m...
June 2, 2025 at 4:22 PM
Reposted by MAD-ID The Antimicrobial Stewardship Meeting
letstalkmicro.bsky.social
Gram-positive bloodstream
Infections

#MADID2025

@erinmccreary.bsky.social @mad-id.bsky.social
June 2, 2025 at 4:25 PM
Reposted by MAD-ID The Antimicrobial Stewardship Meeting
contagionlive.bsky.social
At #MADID2025, Dr. Logan Brock presented that routine fungal blood cultures during sepsis evaluations may offer limited diagnostic value; a more targeted approach may be appropriate. #IDsky #MEDsky @mad-id.bsky.social

Listen here: www.contagionlive.com/view/rethink...
Rethinking Fungal Blood Cultures in Sepsis Workups
Logan Brock, PharmD, presents data at MAD-ID 2025, showing limited diagnostic yield from routine fungal cultures and delayed results compared to standard methods.
www.contagionlive.com
June 2, 2025 at 5:09 PM
Reposted by MAD-ID The Antimicrobial Stewardship Meeting
contagionlive.bsky.social
Wrapping up our final day at #MADID2025 in Orlando! 🦠 💊 @mad-id.bsky.social #IDsky #MEDsky

It was great to learn from & discuss the posters and presentations showcasing important work in infectious diseases & stewardship. Until next year!

Conference coverage: www.contagionlive.com/conference/m...
May 31, 2025 at 1:16 PM
Reposted by MAD-ID The Antimicrobial Stewardship Meeting
contagionlive.bsky.social
🎥 At #MADID2025, Dr. Jiye Park from Massachusetts General Hospital shared data showing no added benefit from extending oral vancomycin after systemic antibiotics for CDI prophylaxis. @mad-id.bsky.social #IDsky #MEDsky

Listen to more of the results here: www.contagionlive.com/view/oral-va...
Oral Vancomycin "Tail" Offers No Added Benefit for CDI Prophylaxis
At MAD-ID 2025, Jiye Park, PharmD, presents findings showing once-daily dosing is effective, with no added benefit from extended vancomycin use after antibiotics.
www.contagionlive.com
May 31, 2025 at 1:08 PM
Reposted by MAD-ID The Antimicrobial Stewardship Meeting
sidpharm.bsky.social
Last day, best day! 🌞 🦠 Check out today's @mad-id.bsky.social‬ line up and have a safe journey home after the conference.

0800: Importance of Prevention and the Patient Experience
1000: What You May Have Missed in ID This Year!
1130: Meet the Professors
May 31, 2025 at 10:01 AM
mad-id.bsky.social
Finishing our final day of #MADID2025 with the acclaimed "What did you miss in ID"

Drs. Zahra Kassamali Escobar and Jamie Wagner will catch us up on critical publications from 2024-2025! 🤓

@sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social
May 31, 2025 at 12:30 PM
mad-id.bsky.social
Starting our 🔥 final day of #MADID2025 with Armando Nahum and Dr. Marin Schweizer speaking on the importance of the ♥️ patient experience and 😷 infection prevention.

@sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social
May 31, 2025 at 12:24 PM
mad-id.bsky.social
Closing out Day 3️⃣ of #MADID2025, Drs. Zahra Kassamali-Escobar and Erin McCreary discuss the Gray in "Gray-M" Positive 🟣 Infections: ⏬ Step Down Therapy - Focus on 💊 Oral and Long Acting 💉 IV Antibiotics!

@sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social
May 30, 2025 at 7:30 PM
Reposted by MAD-ID The Antimicrobial Stewardship Meeting
contagionlive.bsky.social
💡Great afternoon of interviews with insightful takeaways on improving patient care and implementing guidelines! 🦠💊 #MADID2025 @mad-id.bsky.social #IDsky #MEDsky #AMRsky

Stay updated with onsite coverage here: www.contagionlive.com/conference/m...
May 30, 2025 at 5:02 PM